New 'miracle' drug for postpartum depression one step closer to approval

Scientists from Northwell Health's Feinstein Institutes for Medical Research just wrapped up a clinical trial examining the new drug Zuranolone and found more than half of participants saw a full remission of their clinical depression at the end of the trial period.